当前位置： SCI文献检索 > Hepatology International期刊下所有文献 > Acute kidney injury in hepatitis B-related acute-on-chronic liver failure without preexisting liver cirrhosis.

Acute kidney injury in hepatitis B-related acute-on-chronic liver failure without preexisting liver cirrhosis.

Abstract：

BACKGROUND AND AIM:Acute kidney injury (AKI), as defined by the Acute Kidney Injury Network, has been widely investigated in decompensated liver cirrhosis patients. AKI is frequently progressive and independently associated with mortality in these patients. However, in the Asia-Pacific region, the majority of cases of acute-on-chronic liver failure (ACLF) are caused by acute exacerbation of chronic hepatitis B without preexisting cirrhosis. It is not clear whether these patients are at similar risk as those with underlying cirrhosis. METHODS:We performed a retrospective cohort analysis of hepatitis B-related ACLF patients in a single center from January 2004 through December 2011 and evaluated the occurrence of AKI after admission and its relation to the 3-month mortality of ACLF patients. RESULTS:A total of 439 patients with hepatitis B-related ACLF without preexisting cirrhosis were enrolled, and 158 patients (36.0%) developed AKI during hospitalization. ACLF patients with AKI had higher serum creatinine, bilirubin, and INR values and MELD scores as well as more complications compared to those without AKI (p < 0.01). The occurrence of AKI and its stage affect the 3-month mortality of ACLF patients (p < 0.001), and a greater percentage of AKI was found in non-survivors than survivors (56.7 vs. 27.6%, p < 0.001). The cumulative survival of patient with no AKI, AKI stage 1, 2 and 3 was 77.84, 65.46, 41.38 and 27.03%, respectively. CONCLUSIONS:In our study, we observed that AKI was associated with increased 3-month mortality in hepatitis B-related ACLF patients without preexisting cirrhosis. Higher AKI stage predicted a worse prognosis. Our findings support the importance of early identification and timely therapy of AKI in hepatitis B-related ACLF patients.

journal_name

Hepatol Int

journal_title

Hepatology international

authors

Huang Z,Lin C,Fang J,Wang N,Zhou R,Pan C

doi

10.1007/s12072-015-9636-y

subject

Has Abstract

pub_date

2015-07-01 00:00:00

pages

416-23

issue

3

eissn

1936-0533

issn

1936-0541

journal_volume

9

pub_type

杂志文章

相关文献

Hepatology International文献大全
  • Targeting incretin hormones and the ASK-1 pathway as therapeutic options in the treatment of non-alcoholic steatohepatitis.

    abstract：:Non-alcoholic fatty liver disease (NAFLD) is currently one of the leading forms of chronic liver disease, and its rising frequency worldwide has reached epidemic proportions. NAFLD, particularly its progressive variant NASH (non-alcoholic steatohepatitis), can lead to advanced fibrosis, cirrhosis, and HCC. The pathoph...

    journal_title：Hepatology international

    pub_type： 杂志文章,评审

    doi：10.1007/s12072-018-9854-1

    authors： Kovalic AJ,Satapathy SK,Chalasani N

    更新日期：2018-03-01 00:00:00

  • Hepatic stellate cells: fibrogenic, regenerative or both? Heterogeneity and context are key.

    abstract：:Since their original identification, our understanding of the role of hepatic stellate cells in both health and disease continues to grow. Numerous studies have delineated the role of stellate cell activation in contributing to the pool of myofibroblasts responsible for liver fibrosis, and these have resulted in the d...

    journal_title：Hepatology international

    pub_type： 杂志文章,评审

    doi：10.1007/s12072-016-9758-x

    authors： Bansal MB

    更新日期：2016-11-01 00:00:00

  • Association of the Laennec staging system with degree of cirrhosis, clinical stage and liver function.

    abstract：OBJECTIVES:The aim of this study was to investigate the association of the Laennec staging system with degree of cirrhosis, clinical stage and liver function. METHODS:Liver biopsy was performed for 30 patients with hepatitis B cirrhosis to test the content of hydroxyproline in hepatic tissue, judge the degree of cirrh...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-015-9648-7

    authors： Wang W,Li J,Pan R,A S,Liao C

    更新日期：2015-10-01 00:00:00

  • Biology of portal hypertension.

    abstract：:Portal hypertension develops as a result of increased intrahepatic vascular resistance often caused by chronic liver disease that leads to structural distortion by fibrosis, microvascular thrombosis, dysfunction of liver sinusoidal endothelial cells (LSECs), and hepatic stellate cell (HSC) activation. While the basic ...

    journal_title：Hepatology international

    pub_type： 杂志文章,评审

    doi：10.1007/s12072-017-9826-x

    authors： McConnell M,Iwakiri Y

    更新日期：2018-02-01 00:00:00

  • Viscoelastic test-based bleeding risk score reliably predicts coagulopathic bleeding in decompensated cirrhosis and ACLF patients.

    abstract：BACKGROUND AND AIMS:Coagulopathic bleeding risk prediction is challenging in decompensated cirrhosis (DC) by conventional assays. Viscoelastic tests (VETs) are likely to be more useful for assessing coagulation status in these patients. We investigated whether the VET (Sonoclot) parameters with fibrinogen could predict...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-020-10036-y

    authors： Bihari C,Patil A,Shasthry SM,Baweja S,Kumar G,Sarin SK

    更新日期：2020-07-01 00:00:00

  • Evidence of serologic activity in chronic hepatitis B after surface antigen (HBsAg) seroclearance documented by conventional HBsAg assay.

    abstract：BACKGROUND:Possible serologic activity after hepatitis B surface antigen (HBsAg) seroclearance documented by conventional assays in chronic hepatitis B (CHB) has not been thoroughly investigated. METHODS:We determined the levels of serum hepatitis B virus (HBV) DNA, hepatitis B core-related antigen (HBcrAg), and linea...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-012-9354-7

    authors： Seto WK,Tanaka Y,Wong DK,Lai CL,Shinkai N,Yuen JC,Tong T,Fung J,Hung IF,Yuen MF

    更新日期：2012-03-13 00:00:00

  • The utility of noninvasive scores in assessing the prevalence of nonalcoholic fatty liver disease and advanced fibrosis in type 1 diabetic patients.

    abstract：GOALS:The aim of our study is to assess the prevalence of nonalcoholic fatty liver disease (NAFLD) and advanced hepatic fibrosis in patients with type 1 diabetes (T1D) using simple noninvasive scores. BACKGROUND:There is paucity of data on the prevalence of NAFLD in T1D. Moreover, T1D could be a risk factor for advanc...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-017-9840-z

    authors： Singh A,Le P,Lopez R,Alkhouri N

    更新日期：2018-01-01 00:00:00

  • Hepatitis B virus reactivation in patients receiving cancer chemotherapy: natural history, pathogenesis, and management.

    abstract：:Chronic hepatitis B virus (HBV) infection is endemic in the Asian-Pacific region, and reactivation of HBV post-cancer chemotherapy has become an emerging clinical challenge. Patients with detectable serum HBV DNA before chemotherapy and those receiving intensive chemotherapy are particularly at a risk of HBV reactivat...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-011-9279-6

    authors： Liu CJ,Chen PJ,Chen DS,Kao JH

    更新日期：2013-06-01 00:00:00

  • New therapeutic targets in alcoholic hepatitis.

    abstract：:Alcoholic liver disease (ALD) is a leading cause of liver-related morbidity and mortality worldwide. ALD encompasses a spectrum of disorders including asymptomatic steatosis, steatohepatitis, fibrosis, cirrhosis and its related complications, and the acute-on-chronic state of alcoholic hepatitis. While multidisciplina...

    journal_title：Hepatology international

    pub_type： 杂志文章,评审

    doi：10.1007/s12072-015-9701-6

    authors： Arsene D,Farooq O,Bataller R

    更新日期：2016-07-01 00:00:00

  • Actinomycotic hepatic abscess.

    abstract：:Actinomycotic hepatic abscess was diagnosed in a 46-year-old male driver from Ukraine presenting with the symptoms of malaise, loss of appetite, upper right quadrant pain, weight loss, and night sweats which had been present for last 2 months. Computed tomography (CT) of the abdomen revealed a hypodense mass in the le...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-007-9032-3

    authors： Tiftikci A,Vardareli EN,Kaban K,Peker O,Akansel S,Tozun N

    更新日期：2008-03-01 00:00:00

  • Strategies to treat interferon-induced graft dysfunction after living donor liver transplantation for hepatitis C.

    abstract：PURPOSE:Interferon-induced graft dysfunction (IGD) is a poorly defined, unrecognized, but potentially serious condition for patients receiving antiviral drugs after liver transplantation for hepatitis C. METHODS:We evaluated the characteristics of 80 patients who received pegylated interferon-based antiviral treatment...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-013-9496-2

    authors： Ikegami T,Wang H,Yoshizumi T,Toshima T,Aishima S,Fukuhara T,Furusyo N,Kotoh K,Shimoda S,Shirabe K,Maehara Y

    更新日期：2014-04-01 00:00:00

  • The therapeutic response of antiviral therapy in HBsAg-positive renal transplant recipients and a long-term follow-up.

    abstract：BACKGROUND:Early prediction of lamivudine (LAM) response by individualized monitoring of serum HBV DNA like roadmap concept, and investigation of the outcome after LAM discontinuation in renal transplant recipients (RTRs) with chronic hepatitis B (CHB). METHODS:We conducted a study on 19 RTRs with HBV infection receiv...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-011-9295-6

    authors： Hu TH,Tsai MC,Chen YT,Chien YS,Hung CH,Chen TC,Tseng PL,Chang KC,Yen YH

    更新日期：2012-04-01 00:00:00

  • A comparative study of patients' knowledge about hepatitis C in the United States and in urban and rural China.

    abstract：BACKGROUND:Hepatitis C (HCV) is the predominant cause of chronic liver disease in the USA and is increasingly recognized as a common cause of liver disease in China. Studies of HCV patients in the US found major gaps in knowledge but little is known about HCV knowledge among patients in China. METHODS:We conducted a s...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-014-9559-z

    authors： Wu E,Chen X,Guan Z,Cao C,Rao H,Feng B,Chan M,Fu S,Lin A,Wei L,Lok AS

    更新日期：2015-01-01 00:00:00

  • Efficacy of iron chelator deferoxamine for hepatic arterial infusion chemotherapy in advanced hepatocellular carcinoma patients refractory to current treatments.

    abstract：:The prognosis of advanced hepatocellular carcinoma (HCC) remains poor. For patients with advanced HCC, the multikinase inhibitor sorafenib is recommended as the current standard of care. In contrast, hepatic arterial infusion chemotherapy (HAIC) is one of the recommended treatments in Japan. However, in Japan, the use...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-013-9515-3

    authors： Yamasaki T,Saeki I,Sakaida I

    更新日期：2014-09-01 00:00:00

  • A low steady HBsAg seroprevalence is associated with a low incidence of HBV-related liver cirrhosis and hepatocellular carcinoma in Mexico: a systematic review.

    abstract：:To address the relationship between hepatitis B virus (HBV) endemicity and HBV-related liver diseases in Mexico. Research literature reporting on HBsAg and antibody to hepatitis B core antigen (anti-HBc) prevalence in Mexican study groups were searched in NLM Gateway, PubMed, IMBIOMED, and others. Weighted mean preval...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-008-9115-9

    authors： Roman S,Panduro A,Aguilar-Gutierrez Y,Maldonado M,Vazquez-Vandyck M,Martinez-Lopez E,Ruiz-Madrigal B,Hernandez-Nazara Z

    更新日期：2009-06-01 00:00:00

  • Cirrhotic cardiomyopathy.

    abstract：:Cirrhotic cardiomyopathy is a recently recognized condition in cirrhosis consisting of systolic incompetence under condition of stress, diastolic dysfunction related to altered diastolic relaxation, and electrophysiological abnormalities in the absence of any known cardiac disease. It can be diagnosed by using a combi...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-008-9109-7

    authors： Wong F

    更新日期：2009-03-01 00:00:00

  • Balloon-occluded retrograde transvenous obliteration of varices: focusing on the portal hemodynamics and the recent techniques.

    abstract：PURPOSE:To evaluate the recent topics of Ballloon-occluded retrograde trasnvenous obliteration(B-RTO). METHOD:We overviewed the recent scientific papers regarding B-RTO. RESULT:B-RTO is a treatment method for occluding varices retrogradely using a sclerosing agent under balloon occlusion of a major draining vein. It ...

    journal_title：Hepatology international

    pub_type： 杂志文章,评审

    doi：10.1007/s12072-017-9813-2

    authors： Hirota S,Kobayashi K,Kako Y,Takaki H,Yamakado K

    更新日期：2018-02-01 00:00:00

  • Complications constitute a major risk factor for mortality in hepatitis B virus-related acute-on-chronic liver failure patients: a multi-national study from the Asia-Pacific region.

    abstract：BACKGROUND AND AIM:Cirrhosis is a controversial determinant of mortality in HBV-related acute-on-chronic liver failure (HBV-ACLF). The present study aimed to explore the effects of cirrhosis and the associated risk factors, especially its complications, on the outcome of HBV-ACLF. METHODS:A prospective-retrospective c...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-019-09992-x

    authors： Chen T,Yang Z,Choudhury AK,Al Mahtab M,Li J,Chen Y,Tan SS,Han T,Hu J,Hamid SS,Huei LG,Ghazinian H,Nan Y,Chawla YK,Yuen MF,Devarbhavi H,Shukla A,Abbas Z,Sahu M,Dokmeci AK,Lesmana LA,Lesmana CRA,Xin S,Duan Z,

    更新日期：2019-11-01 00:00:00

  • Reversal of NASH fibrosis with pharmacotherapy.

    abstract：:NAFLD is a spectrum of liver disease starting with fatty liver at one end of the spectrum and cirrhosis or liver cancer at the other end. Worldwide, NAFLD has become one of the most common liver diseases and it has also become one of the leading indications for liver transplantation. Our understanding of the NAFLD epi...

    journal_title：Hepatology international

    pub_type： 杂志文章,评审

    doi：10.1007/s12072-019-09970-3

    authors： Alukal JJ,Thuluvath PJ

    更新日期：2019-09-01 00:00:00

  • Efficacy and resistance of entecavir following 3 years of treatment of Japanese patients with lamivudine-refractory chronic hepatitis B.

    abstract：PURPOSE:Lamivudine treatment of chronic hepatitis B (CHB) is associated with frequent resistance and loss of clinical benefit. We present outcomes of lamivudine-refractory Japanese patients treated with entecavir for 3 years. METHODS:Eighty-two patients refractory to lamivudine therapy received entecavir 0.5 or 1 mg d...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-009-9162-x

    authors： Karino Y,Toyota J,Kumada H,Katano Y,Izumi N,Kobashi H,Sata M,Moriyama M,Imazeki F,Kage M,Ishikawa H,Masaki N,Seriu T,Omata M

    更新日期：2010-02-06 00:00:00

  • A changing paradigm: management and treatment of the HCV/HIV-co-infected patient.

    abstract：:Hepatitis C virus (HCV) treatment in HIV/HCV co-infected individuals has renewed relevance given the ongoing opioid crisis and rise of new HIV and HCV infections associated with injection drug use. Patients co-infected with HIV and HCV demonstrate increased rates of hepatic fibrosis, progression to liver failure, and ...

    journal_title：Hepatology international

    pub_type： 杂志文章,评审

    doi：10.1007/s12072-018-9896-4

    authors： Abutaleb A,Sherman KE

    更新日期：2018-11-01 00:00:00

  • Spontaneous bacterial peritonitis from Salmonella: an unusual bacterium with unusual presentation.

    abstract：:Spontaneous bacterial peritonitis (SBP) is a common cause of morbidity and mortality in patients with advanced cirrhosis and portal hypertension. While gram-negative rods and Enterococcus species are the common offending organisms, Salmonella has also been recognized as a rare and atypical offending organism. Atypical...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-008-9087-9

    authors： Rajekar H,Wai CT,Lee KH,Wong SY,Tan KC

    更新日期：2008-09-01 00:00:00

  • Outcomes of patients with chest tube insertion for hepatic hydrothorax.

    abstract：PURPOSE:Case reports and small case series have reported a high rate of complications associated with chest tube placement for hepatic hydrothorax. We describe the in-hospital and 3-month outcomes of patients who have had this procedure. METHODS:A retrospective medical record review was performed of all patients admit...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-009-9136-z

    authors： Orman ES,Lok AS

    更新日期：2009-12-01 00:00:00

  • Predicting clinical outcomes in patients with HBsAg-positive chronic hepatitis.

    abstract：BACKGROUND AND AIMS:The progression of HBsAg-positive chronic hepatitis is insidious and unpredictable. Identification of factors leading to either a benign or more serious clinical outcome may assist in decision making for antiviral therapy. METHODS:From 1989 to 1998, 130 untreated patients with chronic hepatitis wer...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-015-9651-z

    authors： Tong MJ,Huynh TT,Siripongsakun S,Chang PW,Tong LT,Ha YP,Mena EA,Weissman MF

    更新日期：2015-10-01 00:00:00

  • HATT: a phase IV, single-arm, open-label study of sorafenib in Taiwanese patients with advanced hepatocellular carcinoma.

    abstract：BACKGROUND:Sorafenib significantly improves survival in patients with advanced hepatocellular carcinoma (HCC). This phase IV study assessed sorafenib efficacy/safety in Taiwanese patients with advanced HCC and Child-Pugh A status. METHODS:All patients received 400 mg sorafenib BID. Safety, efficacy, sorafenib pharmaco...

    journal_title：Hepatology international

    pub_type： 杂志文章,多中心研究,随机对照试验

    doi：10.1007/s12072-016-9774-x

    authors： Lin SM,Lu SN,Chen PT,Jeng LB,Chen SC,Hu CT,Yang SS,Le Berre MA,Liu X,Mitchell DY,Prins K,Grevel J,Peña CA,Meinhardt G

    更新日期：2017-03-01 00:00:00

  • Impact of viral hepatitis B status on outcomes of intrahepatic cholangiocarcinoma: a meta-analysis.

    abstract：BACKGROUND AND AIMS:To estimate the impact of viral hepatitis B status on outcomes of intrahepatic cholangiocarcinoma. METHODS:We searched Pubmed and Embase for original articles that evaluated the impact of hepatitis B virus infection on outcomes of intrahepatic cholangiocarcinoma. The present study was conducted to ...

    journal_title：Hepatology international

    pub_type： 杂志文章,meta分析,评审

    doi：10.1007/s12072-018-9881-y

    authors： Jeong S,Luo G,Wang ZH,Sha M,Chen L,Xia Q

    更新日期：2018-07-01 00:00:00

  • Sofosbuvir-velpatasvir plus ribavirin in Japanese patients with genotype 1 or 2 hepatitis C who failed direct-acting antivirals.

    abstract：BACKGROUND/PURPOSE:In Japan, there is a growing population of patients with chronic hepatitis C virus (HCV) infection who failed a direct-acting antiviral (DAA)-based regimen. In this Phase 3 study, we evaluated sofosbuvir-velpatasvir plus ribavirin in Japanese patients with genotype 1 or 2 HCV infection who previously...

    journal_title：Hepatology international

    pub_type： 杂志文章,多中心研究,随机对照试验

    doi：10.1007/s12072-018-9878-6

    authors： Izumi N,Takehara T,Chayama K,Yatsuhashi H,Takaguchi K,Ide T,Kurosaki M,Ueno Y,Toyoda H,Kakizaki S,Tanaka Y,Kawakami Y,Enomoto H,Ikeda F,Jiang D,De-Oertel S,McNabb BL,Camus G,Stamm LM,Brainard DM,McHutchison JG,M

    更新日期：2018-07-01 00:00:00

  • C1QTNF1-AS1 regulates the occurrence and development of hepatocellular carcinoma by regulating miR-221-3p/SOCS3.

    abstract：BACKGROUND:The aim of our study was to explore how C1QTNF1-AS1 regulated miR-221-3p/SOCS3 axis in human hepatocellular carcinoma (HCC). METHODS:Differentially expressed lncRNAs and genes were examined via RNA-seq. GO analysis and KEGG pathway enrichment analysis were carried out based on the function of dys-regulated ...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-019-09944-5

    authors： Li H,Zhang B,Ding M,Lu S,Zhou H,Sun D,Wu G,Gan X

    更新日期：2019-05-01 00:00:00

  • Pharmacologic prevention of variceal bleeding and rebleeding.

    abstract：BACKGROUND:Variceal bleeding is a major complication of portal hypertension, which is associated with significant mortality. Moreover, patients surviving a variceal bleeding episode have very high risk of rebleeding, which is associated with mortality as high as that of the first bleed. Because of this, prevention of b...

    journal_title：Hepatology international

    pub_type： 杂志文章,评审

    doi：10.1007/s12072-017-9833-y

    authors： Baiges A,Hernández-Gea V,Bosch J

    更新日期：2018-02-01 00:00:00

  • Obstructive jaundice promotes intestinal-barrier dysfunction and bacterial translocation: experimental study.

    abstract：BACKGROUND:Although clinical and experimental studies have demonstrated a correlation between obstructive jaundice and the development of sepsis, the mechanism has not been fully elucidated. PURPOSE:The aim of this study was to investigate the influence of biliary obstruction on bacterial translocation as a possible s...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-007-9018-1

    authors： Abdeldayem H,Ghoneim E,Refaei AA,Abou-Gabal A

    更新日期：2007-12-01 00:00:00